Technology

India's First Clinical Pharmacology Unit for Renal Patients Installed

The unit would also be utilised for carrying out clinical trials related to urology

Veeda CR, India's fastest growing Clinical Research Organisation (CRO), recently opened it's new Clinical Pharmacology Unit (CPU) at Muljibhai Patel Urological Hospital (MPUH), Nadiad, Gujarat. The unit was inaugurated by Dinsha J Patel, Minister of State for Petroleum & Natural Gas and D Nilima Kshirsagar, Director Professor, Infectious Diseases & Interdisciplinary Research, Maharashtra University of Health Sciences. Veeda will conduct Phase I/II clinical studies in renal impaired patients at the Unit.

Dr Kiran Marthak, Director, Veeda CR, said, "Conducting Phase I studies on renal impaired patients is highly important as many drugs are excreted by the body via the kidneys and a knowledge of the influence of kidney function on drug metabolism is essential to drug development."

Studies involving renal impaired patients are particularly important for newly discovered drugs for which the way in which the body handles the drug is not known. Veeda would also utilise this unit for carrying out clinical trials related to urology like Ca Prostate and Ca Bladder which may necessitate admission in the ward which is in the hospital and immediately adjacent to the intensive care unit. The unit has six fully-monitored beds and all the supporting facilities necessary for the safe conduct of clinical trials.

Veeda CR will have access to the experienced manpower of the hospital as well as the facilities available like kidney dialysis machines, pathology laboratory, X-rays and CT scan. Veeda CR service blends 20 years of phase I expertise in the UK and Germany. With the acquisition of DICE, a highly specialised data management CRO in Brussels, Veeda CR is well placed to deliver cost effective, timely research solutions to the pharmaceutical and biotechnology industries worldwide.

EH News Bureau